{"id":397542,"date":"2020-12-10T10:34:09","date_gmt":"2020-12-10T15:34:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397542"},"modified":"2020-12-10T10:34:09","modified_gmt":"2020-12-10T15:34:09","slug":"neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/","title":{"rendered":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS"},"content":{"rendered":"

<\/p>\n

Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS <\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nHalper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Neos Therapeutics, Inc. (NASDAQ: NEOS) to Aytu BioScience, Inc. is fair to Neos shareholders. Upon the effectiveness of the merger, Neos stockholders are expected to receive 0.1088 shares of Aytu common stock for each share of Neos common stock held.\n<\/p>\n

\nHalper Sadeh encourages Neos shareholders to click here to learn more about their legal rights and options<\/b><\/a> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nThe investigation concerns whether Neos and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Neos shareholders; (2) determine whether Aytu is underpaying for Neos; and (3) disclose all material information necessary for Neos shareholders to adequately assess and value the merger consideration. On behalf of Neos shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.\n<\/p>\n

\nHalper Sadeh encourages Neos shareholders to click here to learn more about their legal rights and options<\/b><\/a> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nHalper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.\n<\/p>\n

\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201210005712\/en\/<\/a><\/span><\/p>\n

\nHalper Sadeh LLP
\n
Daniel Sadeh, Esq.
\n
Zachary Halper, Esq.
\n
(212) 763-0060
\n
sadeh@halpersadeh.com
\n<\/a>
zhalper@halpersadeh.com
\n<\/a>
https:\/\/www.halpersadeh.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Illinois New York<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Neos Therapeutics, Inc. (NASDAQ: NEOS) to Aytu BioScience, Inc. is fair to Neos shareholders. Upon the effectiveness of the merger, Neos stockholders are expected to receive 0.1088 shares of Aytu common stock for each share of Neos common stock held. Halper Sadeh encourages Neos shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation … <\/p>\n

Continue reading “Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397542","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNeos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Neos Therapeutics, Inc. (NASDAQ: NEOS) to Aytu BioScience, Inc. is fair to Neos shareholders. Upon the effectiveness of the merger, Neos stockholders are expected to receive 0.1088 shares of Aytu common stock for each share of Neos common stock held. Halper Sadeh encourages Neos shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation … Continue reading "Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T15:34:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS\",\"datePublished\":\"2020-12-10T15:34:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/\",\"name\":\"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-10T15:34:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/","og_locale":"en_US","og_type":"article","og_title":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS - Market Newsdesk","og_description":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Neos Therapeutics, Inc. (NASDAQ: NEOS) to Aytu BioScience, Inc. is fair to Neos shareholders. Upon the effectiveness of the merger, Neos stockholders are expected to receive 0.1088 shares of Aytu common stock for each share of Neos common stock held. Halper Sadeh encourages Neos shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation … Continue reading \"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T15:34:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS","datePublished":"2020-12-10T15:34:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/","name":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-10T15:34:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201210005712r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neos-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-neos-therapeutics-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-neo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Neos Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Neos Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 NEOS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397542"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397542\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}